Gansu Baishixing Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Chengdu Baishixing Science and Technology Industry Co.,Ltd. It is located in the Lanzhou New Area Chemical Industrial Park, a national level new area, covering an area of over 90 acres. The company currently has over 200 employees and more than 60 engineering and technical personnel. It is a high-tech enterprise that provides large-scale products and technical services for global pharmaceutical companies and research institutions, including raw materials and pharmaceutical intermediates. The company has passed ISO9001 (2015) and quality system certification, as well as safety and environmental inspections. Its products comply with the United States Pharmacopeia (USP), Japanese "Ajinomoto" (AIJ) standards, and European Pharmacopoeia (EP) standards.

Our main products are four series (peptides, protected amino acids and pharmaceutical intermediates, amino acid derivatives, vitamins and their derivatives), focusing on the development and production of small molecule drug raw materials, high-end pharmaceutical intermediates, and new compounds. Our annual output is over 1000 tons, including over 200 tons of peptides and protected amino acids. The company has mastered multiple key core technologies and holds 15 invention patents and 16 utility model patents. The bromine free production of tyrosine disodium and orotic acid fills the domestic gap.

Baishixing has always been based on domestic and international markets, committed to becoming the preferred raw material supplier for the world's pharmaceutical and high-end food industries. To become a leading manufacturer of cell culture media, peptides, and protected amino acids, and to contribute to human health. With first-class quality, first-class service, and cooperation with customers to create a win-win future together.